Itau Unibanco Holding S.A.’s Heron Therapeutics HRTX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-423	Closed	-$8K	–	931
2019 Q3	$8K	Hold	423	–	–	﹤0.01%	287
2019 Q2	$8K	Sell	423 -337	-44%	-$6.73K	﹤0.01%	591
2019 Q1	$18K	Hold	760	–	–	﹤0.01%	565
2018 Q4	$18K	Buy	760 +67	+10%	+$1.84K	﹤0.01%	565
2018 Q3	$22K	Buy	693 +380	+121%	+$14.2K	﹤0.01%	567
2018 Q2	$12K	Buy	+313	New	+$9.96K	﹤0.01%	694

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Itau Unibanco Holding S.A.'s HRTX Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Heron Therapeutics (HRTX) in Q4 2019, closing a stake of 423 shares — an estimated $8K sold.

Itau Unibanco Holding S.A. first reported a position in HRTX in Q2 2018 and held it in 6 quarters. The position peaked at $22K in Q3 2018. 199 funds tracked by Wall St. Rank hold HRTX as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining Heron Therapeutics position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 423 Heron Therapeutics shares in Q4 2019, an estimated $8K.
Itau Unibanco Holding S.A. first reported a position in Heron Therapeutics in Q2 2018 and held it in 6 quarters.
Itau Unibanco Holding S.A.'s Heron Therapeutics position peaked at $22K in Q3 2018.
199 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.